Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Oral > Solid: 600 mg + 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 400 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate, equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus Source: EML workbook import
Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified - Contact with or exposure to human immunodeficiency virus Source: EML workbook import
Formulations: - Oral > Solid: 30 mg + 60 mg Tablet; 150 mg + 300 mg Tablet Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Capsule (modified release): 10 000 lipase units + 8000 amylase units + 600 protease units; 25 000 lipase units + 18 000 amylase units + 1000 protease units. *Units expressed in Ph. Eur Indications: - Enzyme intestinal - Cystic fibrosis Source: EML workbook import
Formulations: - Respiratory > Inhalation > liquid: Indications: - Anaesthetics and therapeutic gases Source: EML workbook import
Formulations: - Respiratory > Inhalation: Indications: - Anaesthetics and therapeutic gases Source: EML workbook import
Formulations: - Respiratory > Inhalation: (medical gas) - Respiratory > Inhalation: Indications: - Anaesthetics and therapeutic gases - Respiratory failure as acute or chronic Source: EML workbook import
Formulations: - Respiratory > Inhalation > liquid: Indications: - Anaesthetics and therapeutic gases Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 10 mg per mL in vial (as hydrochloride); 50 mg per mL in vial (as hydrochloride) Indications: - Anaesthetics and therapeutic gases Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10 mg per mL; 20 mg per mL Indications: - Anaesthetics and therapeutic gases Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
